Ensurge Micropower (ENSU) investor relations material

Executive summary

• Achieved record battery and multi-layer product performance in Q1 2026, with significant improvements in capacity retention and cycle life, advancing toward commercialization and Proof-of-Concept milestones.

• Expanded customer pipeline to over 125 inbound leads, including marquee companies and active negotiations for multi-year development programs across medical, sensor, and AI-driven applications.

• Shifted to a product-led organization, resulting in operational and financial efficiencies, staff reductions, and targeted expertise.

• Attracted top talent, rebalanced the team, and hired a data architect to modernize infrastructure and apply AI-driven analytics.

• Emphasized disciplined execution, transparency, and a culture of continuous improvement.

Financial highlights

• Q1 2026 revenue reached USD 154 thousand, primarily from strategic development and partnership activities, compared to zero in Q1 2025.

• EBITDA less capitalized R&D for Q1 2026 was a loss of USD 3,523 thousand, excluding USD 405 thousand restructuring charges, improving from Q4 2025.

• Operating costs increased to USD 4,082 thousand in Q1 2026, mainly due to changes in R&D capitalization.

• Material and R&D spend reduced by 44% quarter-over-quarter through inventory optimization and lean manufacturing.

• Cash balance decreased by USD 5,208 thousand during Q1 2026, ending at USD 2,706 thousand as of 31 March 2026.

Outlook and guidance

• Commercialization targeted for the remainder of 2026, with a focus on shipping products with repeatable performance and exiting the POC stage.

• Prioritizing platform validation, scalable customer partnerships, and restructuring fixed costs over the next two quarters.

• Additional funding required to extend operational runway beyond early Q3 2026; board actively pursuing new financing.